Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations

Acta Neurochirurgica, Supplementum

Volumn , Issue 105, 2008, Pages 199-206

  Kim, H ^a,b   Marchuk, D A ^c   Pawlikowska, L ^a   Chen, Y ^a   Su, H ^a   Yang, G Y ^a   Young, W L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; inflammation; vascular malformations

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ALPHA 5 BETA 8 INTEGRIN; ALPHA5 INTEGRIN; ANGIOPOIETIN 2; APOLIPOPROTEIN E2; BONE MORPHOGENETIC PROTEIN 9; ENDOGLIN; GELATINASE B; HOMEODOMAIN PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A; ACTIVIN RECEPTOR 2; ACVRL1 PROTEIN, HUMAN; APOLIPOPROTEIN E;

ANGIOGENESIS; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ASSESSMENT; EPITHELIUM CELL; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GERMLINE MICRONUCLEUS; HUMAN; INTRACELLULAR SIGNALING; LOSS OF FUNCTION MUTATION; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; ANIMAL; ARTERIOVENOUS MALFORMATION; BIOLOGICAL MODEL; GENETIC POLYMORPHISM; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

ACTIVIN RECEPTORS, TYPE II; ANIMALS; APOLIPOPROTEINS E; ARTERIOVENOUS MALFORMATIONS; HUMANS; INTERLEUKIN-6; INTRACRANIAL HEMORRHAGES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85052609523     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-09469-3_38     Document Type: Review

References (68)

1. Achrol AS, Pawlikowska L, McCulloch CE, Poon KY, Ha C, Zaroff JG, Johnston SC, Lee C, Lawton MT, Sidney S, Marchuk DA, Kwok PY, Young WL (2006) Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations. Stroke 37:231-234
2. Achrol AS, Kim H, Pawlikowska L, Trudy Poon KY, McCulloch CE, Ko NU, Johnston SC, McDermott MW, Zaroff JG, Lawton MT, Kwok PY, Young WL (2007) Association of tumor necrosis factoralpha-238G>A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment. Neurosurgery 61:731-740
3. Al-Shahi R, Fang JS, Lewis SC, Warlow CP (2002) Prevalence of adults with brain arteriovenous malformations: a community based study in Scotland using capture-recapture analysis. J Neurol Neurosurg Psychiatry 73:547-551
4. Arteriovenous Malformation Study Group (1999) Arteriovenous malformations of the brain in adults. N Engl J Med 340:1812-1818
5. Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, Tang W, Miller F, Mao R (2006) A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 140:2155-2162
6. Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, Gedge F, Tang W, Coon H, Mao R (2006) Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A 140:463-470
7. Berman MF, Sciacca RR, Pile-Spellman J, Stapf C, Connolly ES Jr, Mohr JP, Young WL (2000) The epidemiology of brain arteriovenous malformations. Neurosurgery 47:389-397
8. Brouillard P, Vikkula M (2007) Genetic causes of vascular malformations. Hum Mol Genet 16 (2):R140-R149
9. Calvert JT, Riney TJ, Kontos CD, Cha EH, Prieto VG, Shea CR, Berg JN, Nevin NC, Simpson SA, Pasyk KA, Speer MC, Peters KG, Marchuk DA (1999) Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8:1279-1289
10. Cambier S, Gline S, Mu D, Collins R, Araya J, Dolganov G, Einheber S, Boudreau N, Nishimura SL (2005) Integrin alpha (v) - beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch. Am J Pathol 166:1883-1894
11. Carter N, Williamson L, Kennedy LG, Brown MA, Wordsworth BP (2000) Susceptibility to ankylosing spondylitis. Rheumatology (Oxford) 39:445
12. Chen Y, Xu B, Arderiu G, Hashimoto T, Young WL, Boudreau N, Yang GY (2004) Retroviral delivery of homeobox D3 gene induces cerebral angiogenesis in mice. J Cereb Blood Flow Metab 24:1280-1287
13. Chen Y, Fan Y, Poon KY, Achrol AS, Lawton MT, Zhu Y, McCulloch CE, Hashimoto T, Lee C, Barbaro NM, Bollen AW, Yang GY, Young WL (2006) MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. Front Biosci 11:3121-3128
14. Chen Y, Pawlikowska L, Yao JS, Shen F, Zhai W, Achrol AS, Lawton MT, Kwok PY, Yang GY, Young WL (2006) Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 59:72-80
15. Chen Y, Zhu W, Bollen AW, Lawton MT, Barbaro NM, Dowd CF, Hashimoto T, Yang GY, Young WL (2008) Evidence for inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery (in press)
16. Cole SG, Begbie ME, Wallace GM, Shovlin CL (2005) A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42:577-582
17. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) endothelial cells. Blood 109:1953-1961
18. David L, Mallet C, Vailhé B, Lamouille S, Feige JJ, Bailly S (2007) Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J Cell Physiol 213:484-489
19. Du R, Hashimoto T, Tihan T, Young WL, Perry V, Lawton MT (2007) Growth and regression of arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Case report. J Neurosurg 106:470-477
20. Duong DH, Young WL, Vang MC, Sciacca RR, Mast H, Koennecke HC, Hartmann A, Joshi S, Mohr JP, Pile-Spellman J (1998) Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke 29:1167-1176
21. Gallione CJ, Richards JA, Letteboer TG, Rushlow D, Prigoda NL, Leedom TP, Ganguly A, Castells A, Ploos van Amstel JK, Westermann CJ, Pyeritz RE, Marchuk DA (2006) SMAD4 mutations found in unselected HHT patients. J Med Genet 43:793-797
22. Happle R (1992) Paradominant inheritance: a possible explanation for Becker's pigmented hairy nevus. Eur J Dermatol 2:39-40
23. Happle R (1993) Klippel-Trenaunay syndrome: is it a paradominant trait? Br J Dermatol 128:465-466
24. Hashimoto T, Lam T, Boudreau NJ, Bollen AW, Lawton MT, Young WL (2001) Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res 89:111-113
25. Hashimoto T, Mesa-Tejada R, Quick CM, Bollen AW, Joshi S, Pile-Spellman J, Lawton MT, Young WL (2001) Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery 49:124-132
26. Hashimoto T, Wen G, Lawton MT, Boudreau NJ, Bollen AW, Yang GY, Barbaro NM, Higashida RT, Dowd CF, Halbach VV, Young WL (2003) Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 34:925-931
27. Hashimoto T, Lawton MT, Wen G, Yang GY, Chaly T Jr, Stewart CL, Dressman HK, Barbaro NM, Marchuk DA, Young WL (2004) Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery 54:410-425
28. Hysi PG, Kim H, Pawlikowska L, McCulloch CE, Zaroff JG, Marchuk DA, Lawton MT, Kwok PY, Young WL (2007) Association of interleukin-1 beta (IL1β) gene and risk of intracranial hemorrhage in brain arteriovenous malformation patients (Abstract #2538). 57th Annual Meeting of the American Society of Human Genetics, San Diego, CA
29. Hysi PG, Kim H, Pawlikowska L, McCulloch CE, Zaroff JG, Sidney S, Burchard EG, Marchuk DA, Lawton MT, Kwok PY, Young WL (2007) Association of interleukin-1 beta (IL1B) gene and brain arteriovenous malformation in Caucasians (abstract). Stroke 38:456
30. Inoue S, Liu W, Inoue K, Mineharu Y, Takenaka K, Yamakawa H, Abe M, Jafar JJ, Herzig R, Koizumi A (2007) Combination of linkage and association studies for brain arteriovenous malformation. Stroke 38:1368-1370 (Pubitemid 351664279)
31. Kim H, Sidney S, McCulloch CE, Poon KY, Singh V, Johnston SC, Ko NU, Achrol AS, Lawton MT, Higashida RT, Young WL (2007) Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke 38:2430-2437
32. Lamouille S, Mallet C, Feige JJ, Bailly S (2002) Activin receptorlike kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100:4495-4501
33. Langer DJ, Lasner TM, Hurst RW, Flamm ES, Zager EL, King JT Jr (1998) Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery 42:481-489
34. Lawton MT, Jacobowitz R, Spetzler RF (1997) Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg 87:267-274 (Pubitemid 27349113)
35. Lee CZ, Xue Z, Zhu Y, Yang GY, Young WL (2007) Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage. Stroke 38:2563-2568
36. Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos van Amstel JK, Westermann CJ (2006) Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 43:371-377
37. Maher CO, Piepgras DG, Brown RD Jr, Friedman JA, Pollock BE (2001) Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 32:877-882
38. Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS (2003) Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 12: R97-R112
39. Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, Hacein-Bey L, Duong H, Stein BM, Mohr JP (1997) Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 350:1065-1068
40. Matsubara S, Manzia JL, ter Brugge K, Willinsky RA, Montanera W, Faughnan ME (2000) Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuroradiol 21:1016-1020
41. Meschia JF, Brown RD Jr, Brott TG, Chukwudelunzu FE, Hardy J, Rich SS (2002) The Siblings With Ischemic Stroke Study (SWISS) protocol. BMC Med Genet 3:1
42. Park SO, Lee YJ, Seki T, Hong KH, Fliess N, Jiang Z, Park A, Wu X, Kaartinen V, Roman BL, Oh SP (2008) ALK5-and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111:633-642
43. Pawlikowska L, Tran MN, Achrol AS, McCulloch CE, Ha C, Lind DL, Hashimoto T, Zaroff J, Lawton MT, Marchuk DA, Kwok PY, Young WL (2004) Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke 35:2294-2300
44. Pawlikowska L, Tran MN, Achrol AS, Ha C, Burchard E, Choudhry S, Zaroff J, Lawton MT, Castro R, McCulloch CE, Marchuk D, Kwok PY, Young WL (2005) Polymorphisms in transforming growth factor-beta-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations. Stroke 36:2278-2280
45. Pawlikowska L, Poon KY, Achrol AS, McCulloch CE, Ha C, Lum K, Zaroff JG, Ko NU, Johnston SC, Sidney S, Marchuk DA, Lawton MT, Kwok PY, Young WL (2006) Apoliprotein E epsilon 2 is associated with new hemorrhage risk in brain arteriovenous malformations. Neurosurgery 58:838-843
46. Quick CM, Hashimoto T, Young WL (2001) Lack of flow regulation may explain the development of arteriovenous malformations. Neurol Res 23:641-644
47. Risch N (1990) Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46:222-228
48. Ritvo ER, Jorde LB, Mason-Brothers A, Freeman BJ, Pingree C, Jones MB, McMahon WM, Petersen PB, Jenson WR, Mo A (1989) The UCLA-University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 146:1032-1036
49. Rogers MS, D'Amato RJ (2006) The effect of genetic diversity on angiogenesis. Exp Cell Res 312:561-574
50. Sabba C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, Dicuonzo F, Guant G (2007) Hereditary hemorragic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost 5:1149-1157
51. Satomi J, Mount RJ, Toporsian M, Paterson AD, Wallace MC, Harrison RV, Letarte M (2003) Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke 34:783-789
52. Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L, Lowik CW, ten Dijke P (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120:964-972
53. Shaked Y, Bertolini F, Man S, Rogers MS, Cervi D, Foutz T, Rawn K, Voskas D, Dumont DJ, Ben-David Y, Lawler J, Henkin J, Huber J, Hicklin DJ, D'Amato RJ, Kerbel RS (2005) Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cell 7:101-111
54. Simon M, Franke D, Ludwig M, Aliashkevich AF, Koster G, Oldenburg J, Bostrom A, Ziegler A, Schramm J (2006) Association of a polymorphism of the ACVRL1 gene with sporadic arteriovenous malformations of the central nervous system. J Neurosurg 104:945-949
55. Simon M, Schramm J, Ludwig M, Ziegler A (2007) Response to neurosurgical forum letter to the Editor "Arteriovenous Malformation" by Young et al. J Neurosurg 106:731-733
56. Singh V, Smith WS, Lawton MT, Halbach VV, Young WL (2006) Thrombophilic mutation as a new high-risk feature in DAVF patients (abstract S-99). Ann Neurol 60 (Suppl 3): S30
57. Srinivasan S, Hanes MA, Dickens T, Porteous ME, Oh SP, Hale LP, Marchuk DA (2003) A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 12:473-482
58. Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, Pile-Spellman J, Mohr JP (2003) The New York Islands AVM Study: design, study progress, and initial results. Stroke 34: e29-e33
59. ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857-869
60. Thomas B, Eyries M, Montagne K, Martin S, Agrapart M, Simerman-Francois R, Letarte M, Soubrier F (2007) Altered endothelial gene expression associated with hereditary haemorrhagic telangiectasia. Eur J Clin Invest 37:580-588
61. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M (2005) A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96:684-692
62. Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26:328-331
63. van Beijnum J, van der Worp HB, Schippers HM, van Nieuwenhuizen O, Kappelle LJ, Rinkel GJ, Berkelbach van der Sprenkel JW, Klijn CJ (2007) Familial occurrence of brain arteriovenous malformations: a systematic review. J Neurol Neurosurg Psychiatry 78:1213-1217
64. Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190
65. Wouters V, Limaye N, Uebelhoer M, Mulliken JB, Boon LM, Vikkula M (2007) Sporadic venous malformation is caused by somatic mutations in TIE2 (Abstract). American Society of Human Genetics 57th Annual Meeting, San Diego, CA
66. Xu B, Wu YQ, Huey M, Arthur HM, Marchuk DA, Hashimoto T, Young WL, Yang GY (2004) Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab 24:237-244
67. Young WL, Kader A, Ornstein E, Baker KZ, Ostapkovich N, Pile-Spellman J, Fogarty-Mack P, Stein BM (1996) Cerebral hyperemia after arteriovenous malformation resection is related to "breakthrough" complications but not to feeding artery pressure. The Columbia University Arteriovenous Malformation Study Project. Neurosurgery 38:1085-1095
68. Zhu Y, Lawton MT, Du R, Shwe Y, Chen Y, Shen F, Young WL, Yang GY (2006) Expression of hypoxia-inducible factor-1 and vascular endothelial growth factor in response to venous hypertension. Neurosurgery 59:687-696